AyuVis Research, Inc. logo
AyuVis Research, Inc. logo

AyuVis Research, Inc.

ayuvis.com
ayuvis.com • HQ: Fort Worth, United States • Grant 2024 • 51-200 employees • Likely startup • New
HQ: Fort Worth, United States • Grant 2024 • 51-200 employees • Likely startup • New
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Grants
$3.9M
3 grants · CORDIS
Backers
1
TechFW | Tech Fort Worth
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Grant Apr 2024 $1.6M — CORDIS
Grant May 2022 $2M — CORDIS
Grant Jan 2017 $274k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
TechFW | Tech Fort Worth fund

Overview

COVID-19- and SARS-induced ARDS AyuVis research is developing a new class of drugs to treat complicated respiratory infections such as BPD and PAP with promising preclinical data. Both of these indications are associated with ARDS, which can be induced by the Corona virus.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Fort Worth United States
HQ
CONTACT US
50-200 est. staff
3500 Camp Bowie Blvd, EAD-116J, Fort Worth, TX 76107, USA
company site

Financials

Total raised
$3.9M
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2024 $1.6M Details
Grant 2022 $2M Details
Grant 2017 $274k Details